Article: Effects of Deep Cold Storage on CCI of Sterile Vials
Certain sterile pharmaceutical products require deep cold storage, either at -80˚C or even cryogenic temperatures (down to -196˚C). Studies have shown that deep cold storage temperatures can introduce risk to the container closure integrity (CCI) of vial/rubber stopper combinations traditionally used to fill sterile pharmaceutical products. It is therefore critical that robust development work is done to understand the CCI performance of any primary packaging components used for a product needing deep cold storage and transport temperatures.
Wherever you need support optimizing product and process quality throughout the product lifecycle, LIGHTHOUSE experts are available for you.